These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 21204952)

  • 1. Bordetella dermonecrotic toxin binds to target cells via the N-terminal 30 amino acids.
    Fukui-Miyazaki A; Ohnishi S; Kamitani S; Abe H; Horiguchi Y
    Microbiol Immunol; 2011 Mar; 55(3):154-9. PubMed ID: 21204952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bordetella dermonecrotic toxin exerting toxicity through activation of the small GTPase Rho.
    Fukui A; Horiguchi Y
    J Biochem; 2004 Oct; 136(4):415-9. PubMed ID: 15625308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single amino acid substitution in the enzymatic domain of cytotoxic necrotizing factor type 1 of Escherichia coli alters the tissue culture phenotype to that of the dermonecrotic toxin of Bordetella spp.
    McNichol BA; Rasmussen SB; Meysick KC; O'Brien AD
    Mol Microbiol; 2006 May; 60(4):939-50. PubMed ID: 16677305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bordetella dermonecrotic toxin undergoes proteolytic processing to be translocated from a dynamin-related endosome into the cytoplasm in an acidification-independent manner.
    Matsuzawa T; Fukui A; Kashimoto T; Nagao K; Oka K; Miyake M; Horiguchi Y
    J Biol Chem; 2004 Jan; 279(4):2866-72. PubMed ID: 14597616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic role of Rac in mast cell activation revealed by a cell permeable Bordetella dermonecrotic fusion toxin.
    Stratmann H; Schwan C; Orth JH; Schmidt G; Aktories K
    Cell Signal; 2010 Jul; 22(7):1124-31. PubMed ID: 20211724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and protective effects of Bordetella bronchiseptica subunit vaccines based on the recombinant N-terminal domain of dermonecrotic toxin.
    Wang C; Liu L; Zhang Z; Yan Z; Yu C; Shao M; Jiang X; Chi S; Wei K; Zhu R
    Int Immunopharmacol; 2015 Oct; 28(2):952-9. PubMed ID: 26337750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxin.
    Schmidt G; Goehring UM; Schirmer J; Uttenweiler-Joseph S; Wilm M; Lohmann M; Giese A; Schmalzing G; Aktories K
    Infect Immun; 2001 Dec; 69(12):7663-70. PubMed ID: 11705946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli cytotoxic necrotizing factors and Bordetella dermonecrotic toxin: the dermonecrosis-inducing toxins activating Rho small GTPases.
    Horiguchi Y
    Toxicon; 2001 Nov; 39(11):1619-27. PubMed ID: 11595625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties.
    Munro P; Flatau G; Anjuère F; Hofman V; Czerkinsky C; Lemichez E
    Vaccine; 2005 Apr; 23(20):2551-6. PubMed ID: 15780436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and characterization of the dermonecrotic toxin gene of Bordetella bronchiseptica].
    Xue Y; Zhao Z; Pei J; Wang C; Ding K; Cheng X
    Sheng Wu Gong Cheng Xue Bao; 2011 Dec; 27(12):1722-8. PubMed ID: 22506412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the C-terminal part of Bordetella dermonecrotic toxin as a transglutaminase for rho GTPases.
    Schmidt G; Goehring UM; Schirmer J; Lerm M; Aktories K
    J Biol Chem; 1999 Nov; 274(45):31875-81. PubMed ID: 10542213
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Teruya S; Hiramatsu Y; Nakamura K; Fukui-Miyazaki A; Tsukamoto K; Shinoda N; Motooka D; Nakamura S; Ishigaki K; Shinzawa N; Nishida T; Sugihara F; Maeda Y; Horiguchi Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of Highly Active Recombinant Dermonecrotic Toxin of
    Stanek O; Linhartova I; Holubova J; Bumba L; Gardian Z; Malandra A; Bockova B; Teruya S; Horiguchi Y; Osicka R; Sebo P
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32942577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a receptor-binding domain of Bordetella dermonecrotic toxin.
    Matsuzawa T; Kashimoto T; Katahira J; Horiguchi Y
    Infect Immun; 2002 Jul; 70(7):3427-32. PubMed ID: 12065482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
    Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
    Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM
    Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNF and DNT.
    Hoffmann C; Schmidt G
    Rev Physiol Biochem Pharmacol; 2004; 152():49-63. PubMed ID: 15549605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Bordetella dermonecrotic toxin with the extracellular matrix.
    Fukui-Miyazaki A; Kamitani S; Miyake M; Horiguchi Y
    BMC Microbiol; 2010 Sep; 10():247. PubMed ID: 20868510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the region of rho involved in substrate recognition by Escherichia coli cytotoxic necrotizing factor 1 (CNF1).
    Lerm M; Schmidt G; Goehring UM; Schirmer J; Aktories K
    J Biol Chem; 1999 Oct; 274(41):28999-9004. PubMed ID: 10506148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.